Urinex 36 capsules
Pharco Pharmaceuticals Inc.
Pharco Pharmaceuticals Inc.
Composition
Each enteric coated soft gelatin capsule contains
Active substances
Alpha-Pinene 24.80 mg, Camphene 15 mg, Borneol 10 mg, Beta-Pinene 6.20 mg, Alpha-Fenchone 4 mg, Anethole 4 mg, Cineole 3 mg.
Excipients
Olive Oil.
Description
A combined herbal medicine containing a complex of essential oils and terpenes.
It has spasmolytic, anti-inflammatory, and litholytic (stone-dissolving) effects in the urinary tract.
Helps relax smooth muscles, facilitates the passage of small calculi and sand, and improves urodynamics.
Indications for Use
Adjuvant therapy for urolithiasis in adults and children over 6 years of age after a definite diagnosis has been made by a physician.
Dosage and Administration
Oral. Swallow capsules whole, without chewing, before meals.
Adults and adolescents from 14 years: 1 capsule 4 to 5 times daily.
Children from 6 to 14 years: 1 to 2 capsules twice daily.
Children from 0 to 6 years: No data on efficacy and safety. Not recommended.
Contraindications
Hypersensitivity to any component of the drug.
Severe inflammatory diseases of the kidneys and gastrointestinal tract in the acute phase.
Severe hepatic insufficiency.
Precautions
The drug should be used only after a definite diagnosis of urolithiasis has been established by a doctor to rule out other conditions (e.g., acute surgical pathology).
Conservative management of urolithiasis should be initiated under medical supervision, as stones can cause urinary tract obstruction, hydronephrosis, and infectious complications.
Use with caution in patients taking anticoagulants or drugs whose metabolism is dependent on liver function.
Contains parabens (Sodium Ethyl and Propyl Hydroxybenzoate), which may cause allergic reactions (possibly delayed).
Side Effects
No cases of side effects have been reported at the time of registration.
Theoretically, allergic reactions to components or dyspeptic symptoms are possible.
Pregnancy and Lactation
Pregnancy
No information on human use is available.
Animal studies did not reveal a teratogenic effect.
However, some ingredients can cross the placenta.
Use during pregnancy is only possible if considered essential by the physician.
Lactation
Data on safety during breastfeeding are not available.
Use with caution, weighing the benefit/risk ratio.
Storage Conditions
Store at a temperature not exceeding 30°C in a dry place.
Keep out of the sight and reach of children.
Packaging
Carton box containing 3 blisters, each of 12 enteric coated soft gelatin capsules, with an insert leaflet.